Chromoblastomycosis: a contemporary review of a neglected disease
- 14 May 2025
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (5) , 696-705
Abstract
Of the melanized fungal infections affecting humans, chromoblastomycosis (CBM) remains the most prevalent. Also known as chromomycosis, this condition typically manifests as insidious-onset cutaneous lesions that eventually progress to cause physical disability. CBM is considered a neglected tropical disease (NTD) by the World Health Organization because of its significant impact on populations living in poverty throughout tropical regions, the paucity of research, and the opportunity to improve treatment and prevention. In many individuals, the diagnosis is delayed and this is thought to be because of the multitude of clinical mimics and the lack of general awareness. Furthermore, the subcutaneous invasion of this infection creates therapeutic challenges. A small number of studies have identified partially successful treatments and potential pharmacological targets. In this article we present an updated review of this condition to give a contemporary perspective on a neglected disease.Keywords
This publication has 94 references indexed in Scilit:
- Urban chromoblastomycosis: a diagnosis that should not be neglectedAnais Brasileiros de Dermatologia, 2023
- Neutrophil Extracellular Traps Serve as Key Effector Molecules in the Protection Against Phialophora verrucosaMycopathologia, 2021
- A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi Successfully Treated by Oral Itraconazole Together with TerbinafineDermatology and Therapy, 2020
- Chromoblastomycosis caused by Rhinocladiella aquaspersa: first case report in GuatemalaAnais Brasileiros de Dermatologia, 2019
- Photodynamic Therapy Combined with Terbinafine Against Chromoblastomycosis and the Effect of PDT on Fonsecaea monophora In VitroMycopathologia, 2014
- Cromomicosis. Respuesta al tratamiento combinado con crioterapia y terbinafinaActas Dermo-Sifiliograficas, 2014
- Chromoblastomycosis as an endemic disease in temperate Europe: first confirmed case and review of the literatureEuropean Journal of Clinical Microbiology & Infectious Diseases, 2013
- Challenges in the Therapy of ChromoblastomycosisMycopathologia, 2013
- Tropical dermatology: Fungal tropical diseasesJournal of the American Academy of Dermatology, 2005
- Chromoblastomycosis Produced by Aureobasidium pullulans in an Immunosuppressed PatientArchives of Dermatology, 1997